Pareto

ParetoHealth to Accelerate Growth with Strategic Investment from Warburg Pincus

Retrieved on: 
Monday, June 5, 2023
REV Media Group, Insurance, LLP, Warburg Pincus, Partnership, Health, Tyburn, The Company, Growth, Pareto, Health insurance, Health care, Great Hill

PHILADELPHIA, June 5, 2023 /PRNewswire/ -- Pareto Health, Inc. ("ParetoHealth" or the "Company"), the employee benefits platform of choice for thousands of businesses, today announced a significant investment from Warburg Pincus, a leading global growth investor. Great Hill Partners, which invested in ParetoHealth in 2019, will retain an equal stake to Warburg Pincus, alongside a significant continuing investment from the current management team. This investment will support ParetoHealth's mission to make self-insurance accessible for small and midsized employers, reduce volatility, and drive down the overall cost of healthcare.

Key Points: 
  • PHILADELPHIA, June 5, 2023 /PRNewswire/ -- Pareto Health, Inc. ("ParetoHealth" or the "Company"), the employee benefits platform of choice for thousands of businesses, today announced a significant investment from Warburg Pincus, a leading global growth investor.
  • Great Hill Partners, which invested in ParetoHealth in 2019, will retain an equal stake to Warburg Pincus, alongside a significant continuing investment from the current management team.
  • "We look forward to partnering with the Pareto team and Great Hill Partners to drive sustainable growth," added Cem Behmoaram, Principal, Warburg Pincus.
  • Goodwin Procter LLP and Kurtz & Revness LLP provided legal advice to the Company and Kirkland & Ellis LLP and William Blair advised Warburg Pincus.

Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares

Retrieved on: 
Thursday, June 1, 2023
Attention, Diabetic retinopathy, Telephone, BofA Securities, Secure Federal File Sharing Act, OCS, Arctica Finance, Sale, Prospectus, State Street, SVB, Form, Pecten oculi, SVB Securities, Pareto, Life insurance

ZUG, Switzerland and BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the pricing of a follow-on public offering of 3,500,000 ordinary shares at a public offering price of $11.50 per ordinary share, for gross proceeds of $40.25 million, before deducting underwriting discounts and commissions and offering expenses.

Key Points: 
  • ZUG, Switzerland and BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the pricing of a follow-on public offering of 3,500,000 ordinary shares at a public offering price of $11.50 per ordinary share, for gross proceeds of $40.25 million, before deducting underwriting discounts and commissions and offering expenses.
  • In addition, Oculis has granted the underwriters a 30-day option to purchase up to an additional 525,000 ordinary shares on the same terms and conditions.
  • The offering is expected to close on or about June 5, 2023, subject to satisfaction of customary closing conditions.
  • BofA Securities and SVB Securities are acting as joint book-running managers for this offering.

Oculis Announces Launch of Proposed Public Offering of Ordinary Shares

Retrieved on: 
Tuesday, May 30, 2023
Attention, Diabetic retinopathy, Telephone, BofA Securities, OCS, Arctica Finance, Sale, Prospectus, State Street, SVB, Form, Pecten oculi, SVB Securities, Pareto, Life insurance, Security (finance)

ZUG, Switzerland and BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the launch of a follow-on public offering of 5,000,000 ordinary shares.

Key Points: 
  • ZUG, Switzerland and BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the launch of a follow-on public offering of 5,000,000 ordinary shares.
  • In addition, Oculis expects to grant the underwriters a 30-day option to purchase up to an additional 15% of ordinary shares to be sold in the offering on the same terms and conditions.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.
  • All of the securities in the offering are to be sold by Oculis.

2023 Louisiana Energy Conference to Be Held in New Orleans May 30 – June 1, 2023

Retrieved on: 
Wednesday, May 24, 2023
Bloomberg Television, Saint Motel, Politics, LEC, Phibro, Carbon, Harvard University, The Ritz-Carlton Hotel Company, Wind, Stockholm School of Economics, Institute for Research in Economics and Business Administration, Foreign Service, Rystad Energy, Master of Science, Partnership, ESG, Commodity, Conference, Pareto, Stockholm School (economics), Financial adviser, Nightclub, Energy, Economics, LNG, Gulf of Mexico

NEW ORLEANS, May 24, 2023 (GLOBE NEWSWIRE) -- The 2023 Louisiana Energy Conference (“LEC”) will be held in New Orleans at the Ritz-Carlton, New Orleans at 921 Canal Street May 30 – June 1, 2023.

Key Points: 
  • NEW ORLEANS, May 24, 2023 (GLOBE NEWSWIRE) -- The 2023 Louisiana Energy Conference (“LEC”) will be held in New Orleans at the Ritz-Carlton, New Orleans at 921 Canal Street May 30 – June 1, 2023.
  • LEC will feature a series of 27 panels and presentations that will address key domestic and international industry developments and topics.
  • LEC is pleased to announce that this year’s keynote speaker will be Nadia Martin Wiggen, Partner in Energy and Commodities at Pareto Securities.
  • Nadia advises companies and institutional investors within the commodities space, focusing on energy and security for Pareto Securities.

EQS-News: Pareto Securities AS: Pareto Securities: High primary market activity underlines improved sentiment in the Nordic High Yield Bond market. Pareto underpins role as leading arranger in the market

Retrieved on: 
Wednesday, April 26, 2023
Advertising, Media, EUR, Mutares, Acquisition, Bookrunner, Risk management, Security (finance), Pareto

Pareto Securities AS: Pareto Securities: High primary market activity underlines improved sentiment in the Nordic High Yield Bond market.

Key Points: 
  • Pareto Securities AS: Pareto Securities: High primary market activity underlines improved sentiment in the Nordic High Yield Bond market.
  • Pareto Securities: High primary market activity underlines improved sentiment in the Nordic High Yield Bond market.
  • The Nordic High Yield Bond market saw strong activity in the first three months of 2023, spurred by a cautiously optimistic market sentiment.
  • Lutz Weiler, CEO Pareto Securities Germany, comments: "In recent months, we benefitted from the dynamic development in the Nordic High Yield Bond market and once again underpinned our position as the leading Nordic High Yield Bond arranger.

Aruba Collaborates with Microsoft and reelyActive to Speed the Migration of IoT Workloads to Microsoft Azure without Custom Engineering

Retrieved on: 
Tuesday, March 14, 2023
Software, Networks, Hardware, Data Management, Technology, Apps, Applications, IOT (Internet of Things), Mobile, Wireless, Pareto, Abstract, HPE, NYSE, Internet of things, BLE, Organization, Hewlett Packard Enterprise, APS, Economics, GitHub, Temperature, Microsoft Azure, Multimedia, Microsoft Power BI, JSON, Microsoft, Video game, Customer service, Azure

View the full release here: https://www.businesswire.com/news/home/20230314005414/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230314005414/en/
    Speed the migration of IoT workloads to Microsoft Azure without custom engineering (Graphic: Business Wire)
    Integrating data from legacy IoT devices with IoT cloud services can entail months of custom engineering.
  • Once received at the Azure IoT Hub, all of the IoT payloads need to be separately formatted for use by Azure IoT applications.
  • “IoT Transport for Microsoft Azure transforms any Aruba IT network into a secure Azure gateway that lands at the Azure IoT Hub,” said Michael Tennefoss, Aruba’s Vice President of IoT and Strategic Partnerships.
  • “Used in tandem, IoT Transport for Microsoft Azure and Pareto Anywhere for Azure will significantly cut the time required to migrate IoT workloads to Azure,” said Tony Shakib, Microsoft’s General Manager Azure Light Edge and IoT.

Minesto publishes prospectus in connection to the rights issue

Retrieved on: 
Monday, February 27, 2023
Baker McKenzie, Bookrunner, Rights issue, Prospectus, Pareto, Mackenzie, SEB Group, Swedish financial transaction tax, MAQS, Rare-earth element, Automotive industry, Security (finance)

GÖTEBORG, Sweden, Feb. 27, 2023 /PRNewswire/ -- On 2 February 2023, Minesto AB ("Minesto" or the "Company") announced that the board of directors had resolved on a rights issue of up to approximately SEK 153 million (the "Rights Issue"), conditional on the approval of an extraordinary general meeting.

Key Points: 
  • GÖTEBORG, Sweden, Feb. 27, 2023 /PRNewswire/ -- On 2 February 2023, Minesto AB ("Minesto" or the "Company") announced that the board of directors had resolved on a rights issue of up to approximately SEK 153 million (the "Rights Issue"), conditional on the approval of an extraordinary general meeting.
  • On 20 February 2023, the extraordinary general meeting approved the Rights Issue, which the Company announced the same day.
  • Today, Minesto announces that the prospectus relating to the Rights Issue has been approved by the Swedish Financial Supervisory Authority and has been made available on Minesto's webpage, www.minesto.com/investors/rights-issue-2023 , together with all other information related to the Rights Issue.
  • MAQS Advokatbyrå is legal adviser to the Company and Baker & McKenzie Advokatbyrå is legal adviser to the Joint Global Coordinators and Bookrunners in connection with the Rights Issue.

EQS-News: Pareto Securities AS: Pareto Securities advises APK AG on strategic partnership with LyondellBasell and KIRKBI

Retrieved on: 
Sunday, February 12, 2023
Plastic, Conference, Clean technology, LyondellBasell, APK, Environment, DATE, Partnership, Politics, EUR, CO2, Greentech, Pareto, Recycling, AG, Financial services, Risk management

APK AG and its shareholders, together with LyondellBasell Industries Holdings NV ("LyondellBasell"), one of the world’s largest plastics, chemicals and refining companies and KIRKBI A/S ("KIRKBI"), the family-owned holding and investment company of the LEGO® brand, announce the signing of a strategic partnership.

Key Points: 
  • APK AG and its shareholders, together with LyondellBasell Industries Holdings NV ("LyondellBasell"), one of the world’s largest plastics, chemicals and refining companies and KIRKBI A/S ("KIRKBI"), the family-owned holding and investment company of the LEGO® brand, announce the signing of a strategic partnership.
  • Under the terms of the partnership, the parties have agreed to invest equity capital of EUR 130 million in APK.
  • Pareto Securities acted as financial advisor in the transaction and is also advising APK on project financing in the context of the expansion of the Newcycling® facilities.
  • Further information can also be found on the homepage of Pareto Securities https://paretosec.com/ in the "Events and Conferences" section.

EQS-News: ​​​​​​​Pareto Securities AS publishes buy recommendation for Epigenomics AG share

Retrieved on: 
Sunday, January 22, 2023
Cancer, Clinical trial, ECX, Epigenomics, Research, News, Multiomics, Colorectal cancer, Pareto, OTCQX, Research report, CRC, Centers for Medicare & Medicaid Services, Particle-size distribution, FDA, Epigenomics AG, CMS, Medicare, Pharmaceutical industry

Berlin (Germany), December 23, 2022 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Company") announces that Pareto Securities AS has published an updated research report upgrading Epigenomics AG's share and issuing a buy recommendation.

Key Points: 
  • Berlin (Germany), December 23, 2022 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Company") announces that Pareto Securities AS has published an updated research report upgrading Epigenomics AG's share and issuing a buy recommendation.
  • Greg Hamilton, CEO of Epigenomics AG: "We are very pleased with the buy recommendation, which we believe reflects the strong test results Epi proColon "Next-Gen" has achieved in the preclinical study.
  • For the upcoming clinical trial, the number of cancer cases in our pre-clinical data exceeds the necessary number to obtain FDA approval.
  • We are very confident that our test will confirm the preclinical performance data in the prospective clinical trial and thus achieve reimbursement by CMS."

EQS-News: Fiven ASA - Approval of written procedure and amendments to the terms and conditions of the bonds

Retrieved on: 
Sunday, December 18, 2022
ASA, London Stock Exchange, Partnership, RNS, London, Proposal, CFO, ISIN, News, EU, Financial Conduct Authority, Pareto, United Kingdom, Security (finance), Financial adviser, Medical device, Bond

A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of the bondholders voted to approve the Proposal.

Key Points: 
  • A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of the bondholders voted to approve the Proposal.
  • Pareto Securities AB acted as financial advisor in connection with the written procedure.
  • For further questions to Fiven ASA, please contact: Stein Erik Ommundsen, CFO, at [email protected] or + 47 97 510 481.
  • This information is information that Fiven ASA is obliged to make public pursuant to the EU Market Abuse Regulation.